MiR-34a inhibition enhances tumor growth in vivo. (A) Weight of tumor xenografts excised from SCID mice after miR-34a knockdown. (B) Representative tumor xenografts excised from SCID mice. (C) Representative picture of SCID mice receiving subcutaneous inoculation of BeWo cells before excising for tumor xenografts. (D) Representative views of expression of DLL1 in xenografts upon miR-34a knockdown or scramble knockdown (Magnification: 200×).
Pang et al. BMC Cancer 2013 13:25 doi:10.1186/1471-2407-13-25